“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Biogen
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. F...
| C-Level 46 | VP - Level100 |
| Director1067 | Manager1754 |
| Others2852 | |
| Structure | Email Format |
|---|---|
| <first>_<last>@ | John_Smith@biogen.com |
| <last><f>@ |
Smith |
| <first>.<last>@ | John.Smith@biogen.com |
| <first><l>@ |
John |
| <last>@ | Smith@biogen.com |
| Pain Points | Locations | Technologies |
|---|---|---|
| Account Payable | Diegem, Flemish Region, Belgium | |
| Account Payable | Milton Ernest, England, United Kingdom | payment, hoc |
| Account Payable | Triangle, NC | quality assurance, communication, continuous improvement, cgmp, compliance, assessment, k, financial, gmp |
| Account Receivable | Diegem, Flemish Region, Belgium | |
| Account Receivable | Milton Ernest, England, United Kingdom | payment, hoc |
Biogen looking to hire in Artificial Intelligence in Grand Rapids, MI
Biogen looking to hire in Artificial Intelligence in Munich, Bavaria, Germany
Biogen looking to hire in Application Development in Munich, Bavaria, Germany
Aws
Adobe creative cloud
Alteryx
Amazon connect
Atlassian jira
Agile
Application lifecycle management (alm)
Application security
Ci/cd
Devops
We are recruiting for a field-basedRare Disease Partner, SwitzerlandAbout This RoleThe Rare Disea...
View MoreAbout This RoleBiogen is seeking an experienced leader to serve as the Director of Environmental,...
View MoreAbout This RoleJoining us as Key Account Manager, your role is central to ensuring we continue to...
View MoreAbout This RoleAs Pricing, Reimbursement and Tender Manager, you will be an integral part of the ...
View MoreAbout This RoleAs the Head of Culture and Inclusion, you will be at the forefront of shaping and ...
View MoreExcellent opportunity for an attorney with significant corporate and securities law experience at...
View MoreFur unseren Auendienst suchen wir aktuel einen(Sr) Account Manager Biosimilars/Immunologie (w/m/d...
View MoreAbout This RoleAt Biogen, the Data Management and Analytics (DMA) department serves as a cornerst...
View MoreCAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage
Read MoreBiogen Inc: * Biogen completes acquisition of Alcyone Therapeutics -November 14, 2025 at 04:07 pm EST - MarketScreener.
Read MoreWilliam Blair analyst Myles Minter has reiterated their bullish stance on BIIB stock, giving a Buy rating on October 17. Myles Minter has given his Buy
Read MoreEisai and Biogen announced in early October that the U.S. launch of LEQEMBI IQLIK, a subcutaneous autoinjector formulation for Alzheimer's disease,
Read MoreFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we...
Biogen operates in the Biotechnology research industry.
Biogen's revenue is $9.68b
Biogen has 5001 - 10000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.